Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19

Nat Med. 2022 Jan;28(1):53-58. doi: 10.1038/s41591-021-01639-5. Epub 2022 Jan 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Humans
  • Immunization, Passive
  • Risk
  • SARS-CoV-2